The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 13, 2023

Filed:

Oct. 07, 2021
Applicant:

Immuneonco Biopharmaceuticals (Shanghai) Inc., Shanghai, CN;

Inventors:

Wenzhi Tian, Shanghai, CN;

Song Li, Shanghai, CN;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 38/17 (2006.01); C07K 16/30 (2006.01); C07K 16/46 (2006.01); C07K 16/28 (2006.01); C12N 15/63 (2006.01); A61P 35/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39558 (2013.01); A61K 38/177 (2013.01); A61P 35/00 (2018.01); C07K 16/2827 (2013.01); C07K 16/30 (2013.01); C07K 16/3046 (2013.01); C07K 16/3061 (2013.01); C07K 16/468 (2013.01); C12N 15/63 (2013.01); A61K 2039/505 (2013.01); C07K 2317/51 (2013.01); C07K 2317/515 (2013.01);
Abstract

The present application provides a recombinant fusion protein containing an anti-PD-L1 antibody or an antibody fragment thereof, with each paratope of the anti-PD-L1 antibody or antibody fragment thereof linked via a linker to an extracellular Ig-like domain of a signal-regulatory protein (SIRP) at N-terminus of a heavy chain variable region or a light chain variable region constituting the paratope, wherein the recombinant fusion protein can bind to CD47, PD-L1 and FcR simultaneously. The present application also provides a nucleic acid molecule encoding the recombinant fusion protein, an expression vector containing the nucleic acid molecule, a method for producing the recombinant fusion protein and a method for treating a disease associated with over-expression of CD47 and/or PD-L1 using the recombinant fusion protein.


Find Patent Forward Citations

Loading…